C. Davies,H. Pan,J. Godwin.C. Davies,H. Pan.C. Davies.Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial,2012...
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATL... Background For women with oestrogen receptor (ER)-positive early breast cancer, treatment with tamoxifen for 5 years substantially reduces the...
Abstract The impressive first results of the Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) and the adjuvant Tamoxifen To offer more (aTTom) trials both demonstrate that 10 years of tamoxifen is superior to five years of treatment. T... JV Craig - 《J Natl Cancer Inst》 被引量: 38发表...
I went to a 2nd oncologist who conned me into tamoxifen for 6 months which put me into chemical menopause. He then told me I still needed cut poison and burn and I said bye bye! I have since done loads of things including veganism budwig supplements, and cutting out all toxic products...
July 7, 2021 at 10:22 AM I also stopped a little early. I was on Tamoxifen for 8 1/2 years – I switched to Arimidex after 2 years but had such horrible joint pain that my oncologist switched me back to Tamoxifen almost immediately. since I had very few side effects...
[13] They were randomized to a SERM (either toremifene or tamoxifen) and a bisphosphonate (clodronate) versus a SERM with a placebo. During the 3 years of the study, the SERM/placebo group had significant bone loss at the spine, whereas the SERM/bisphosphonate group remained stable. Neither...
The study included a reasonable number of women who had stopped taking tamoxifen 2 to 5 years or more before the index date; these women also had an increased risk of developing endometrial cancer. In previous studies, former users were also found to experience very similar risk increases to ...